Acadia Healthcare (NASDAQ:ACHC) Downgraded by StockNews.com

StockNews.com cut shares of Acadia Healthcare (NASDAQ:ACHC) from a hold rating to a sell rating in a research report released on Tuesday morning.

ACHC has been the subject of several other research reports. Bank of America decreased their price target on Acadia Healthcare from $105.00 to $90.00 and set a buy rating for the company in a report on Thursday, May 2nd. Royal Bank of Canada reissued an outperform rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Monday, March 4th. TheStreet raised shares of Acadia Healthcare from a c rating to a b- rating in a research report on Monday, March 4th. UBS Group lifted their target price on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a buy rating in a research report on Wednesday, February 28th. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a sell rating to a hold rating and set a $70.00 target price for the company in a report on Thursday, April 25th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of Moderate Buy and a consensus target price of $87.56.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $63.58 on Tuesday. The stock’s 50 day moving average price is $72.26 and its two-hundred day moving average price is $76.82. The stock has a market capitalization of $5.90 billion, a price-to-earnings ratio of -454.11, a PEG ratio of 1.98 and a beta of 1.31. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. Acadia Healthcare has a 52-week low of $63.10 and a 52-week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, May 2nd. The company reported $0.84 EPS for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business had revenue of $768.10 million during the quarter, compared to analyst estimates of $779.20 million. During the same period in the previous year, the company posted $0.75 EPS. The firm’s revenue was up 9.1% compared to the same quarter last year. On average, equities analysts predict that Acadia Healthcare will post 3.53 earnings per share for the current year.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 2.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. Campbell & CO Investment Adviser LLC boosted its stake in shares of Acadia Healthcare by 177.4% during the third quarter. Campbell & CO Investment Adviser LLC now owns 7,357 shares of the company’s stock valued at $517,000 after purchasing an additional 4,705 shares during the period. Vaughan Nelson Investment Management L.P. purchased a new stake in Acadia Healthcare during the 4th quarter valued at $24,157,000. Louisiana State Employees Retirement System bought a new stake in Acadia Healthcare in the 4th quarter worth $2,014,000. Phocas Financial Corp. purchased a new position in shares of Acadia Healthcare in the fourth quarter valued at about $6,887,000. Finally, Sivik Global Healthcare LLC boosted its holdings in shares of Acadia Healthcare by 20.0% during the fourth quarter. Sivik Global Healthcare LLC now owns 90,000 shares of the company’s stock worth $6,998,000 after purchasing an additional 15,000 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.